microRNAs are 18-25 nucleotide regulatory RNAs produced through a multi-step pathway: pri-miRNA transcription, nuclear processing by Drosha to pre-miRNA, cytoplasmic processing by Dicer to mature miRNA, and loading onto RISC complexes. They regulate gene expression post-transcriptionally by base-pairing to mRNA 3' UTRs, promoting mRNA degradation or translation inhibition. A single miRNA can regulate hundreds of targets.
Follow a specific miRNA (e.g., miR-21 or let-7) through its entire biogenesis pathway and into RISC-mediated target silencing. Map target mRNAs using computational prediction tools.
From your understanding of transcription and RNA processing, you know that cells produce many types of RNA beyond mRNA, and that RNA molecules undergo extensive processing before they are functional. MicroRNAs (miRNAs) are a class of small non-coding RNAs, typically 18-25 nucleotides long, that act as post-transcriptional gene regulators — they fine-tune protein output by targeting messenger RNAs for degradation or translational repression. Despite their tiny size, miRNAs collectively regulate an estimated 60% of all human protein-coding genes.
The biogenesis pathway is a multi-step maturation process spanning two cellular compartments. It begins in the nucleus, where RNA polymerase II transcribes a primary miRNA (pri-miRNA) — a long transcript that folds into one or more hairpin structures. The nuclear enzyme Drosha (a ribonuclease III), working with its partner protein DGCR8, recognizes the hairpin and cleaves it at the base, releasing a ~70-nucleotide precursor miRNA (pre-miRNA) with a characteristic stem-loop structure and a 2-nucleotide 3' overhang. Exportin-5 then transports the pre-miRNA through the nuclear pore into the cytoplasm. There, a second ribonuclease III enzyme, Dicer, cuts off the loop, producing a short double-stranded RNA duplex of ~22 base pairs. One strand (the guide strand) is loaded onto an Argonaute protein to form the RNA-induced silencing complex (RISC), while the other strand (the passenger strand, or miRNA*) is typically degraded.
Target recognition depends on a surprisingly short stretch of complementarity. The seed region — nucleotides 2-8 at the 5' end of the mature miRNA — is the primary determinant of target specificity. When the seed region base-pairs with a complementary sequence in the 3' untranslated region (3' UTR) of an mRNA, RISC silences that target. In animals, the match is usually imperfect beyond the seed, which leads to translational repression and mRNA destabilization rather than direct cleavage. This partial-matching rule is why a single miRNA can regulate hundreds of different mRNAs — any transcript with a seed-complementary site in its 3' UTR is a potential target.
The biological consequence is a vast regulatory network. The miRNA let-7, one of the first discovered, targets multiple oncogenes and acts as a tumor suppressor; its loss is associated with lung and other cancers. Conversely, miR-21 is an "oncomiR" — overexpressed in nearly every cancer type, where it silences tumor suppressor mRNAs. Beyond cancer, miRNAs orchestrate development (miR-1 drives muscle differentiation), immune responses, and metabolism. Because each miRNA has many targets, and each mRNA can be regulated by multiple miRNAs, the system creates a combinatorial regulatory layer that buffers gene expression noise and coordinates complex cellular programs — a theme you will see amplified when you study other non-coding RNAs like long non-coding RNAs.
No topics depend on this one yet.